Sp 9 - analogs
| Prices in pharmacies: Instructions Sp 9 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Rivaroxaban ✘ (incl) Amiodarone ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 40% Kid 10 neutral
- 40% St 41 neutral
- 34% Gb 34 neutral
- 33% Sp 10 neutral
- 32% Sp 2 neutral
- 32% Bl 25 neutral
- 31% Sp 5 neutral
- 30% Bl 40 neutral
- 30% St 37 neutral
- 29% Bl 20 neutral
- 28% Ren 5 neutral
- 28% Ren 14 neutral
- 28% Ren 13 neutral
- 26% Sp 6 neutral
- 26% Sp 8 neutral
- 25% Sp 3 neutral
- 25% Sp 1 neutral
- 24% Lu 5 neutral
- 24% Bl 22 neutral
- 23% St 25 neutral
- 23% Kid 6 neutral
- 23% St 40 neutral
- 23% Ren 3 neutral
- 23% Ren 8 neutral
- 23% Gb 37 neutral
- 23% St 43 neutral
- 22% Gb 41 neutral
- 21% Liv 14 neutral
- 21% Sp 4 neutral
- 21% St 45 neutral
- 21% Gb 24 neutral
- 20% L.i. 3 neutral
- 20% Bl 27 neutral
- 20% Bl 48 neutral
- 19% Gb 40 neutral
- 19% L.i. 10 neutral
- 18% Bl 57 neutral
- 18% St 44 neutral
- 18% Liv 5 neutral
- 18% St 39 neutral
- 18% P 5 neutral
- 17% Kid 3 neutral
- 17% P 6 neutral
- 17% Kid 8 neutral
- 17% Ren 11 neutral
- 16% Gb 25 neutral
- 16% Ren 12 neutral
- 16% Bl 56 neutral
- 16% Liv 8 neutral
- 16% Sp 17 neutral
Learn more about the selection of analogues
- The drug has «Sp 9» no complete analogues; 51 analog by action, the most similar - Kid 10 .
- Medical online service has selected the best substitutes for Sp 9 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Sp 9 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.